Randolph S. Carpio – CEO
Mr. Carpio has over 25 years of industry experience, his most recent position as Vice President of Quintiles Transnational, he was a Partner of VCG & Associates, acquired by Quintiles Transnational in 2011. His responsibility was managing a product launch team of access and reimbursement specialists in managed care and trade. His team’s reach had access to over 85% of managed lives in the United States. Mr. Carpio has participated in launching over 120 products in his career covering all aspects from product marketing, P&L, 3PL, sales management, trade and account management.
Mr. Carpio was Sr. Director with NDCHealth, his responsibility for the Wall Street development group provided market intelligence to the pharmaceutical and biotech sectors, financial institutions, research centers and media organizations. In this role he developed new information products for pharmaceutical manufacturers within managed care and pharmacy.
Prior to NDCHealth, Mr. Carpio was a Director, National Accounts for AstraZeneca, launching their portfolio of products. In an earlier role, Mr. Carpio was responsible for the marketing of Toprol-XL®; an opportunity he identified to seek an indication in CHF for this product. With the conclusion of the MERIT-HF trial, Toprol-XL® was one of AstraZeneca’s lead products achieving over $1.3B annually. Mr. Carpio served in various sales and management roles during his tenure with AstraZeneca. He received his Bachelor of Science Degree in Business from Northern Arizona University
Leon Barstow, Ph.D. – Chief Scientific Officer
Dr. Barstow is an executive with experience in new business development in a variety of biotechnology fields. Prior to Dr. Barstow’s position as Chairman, Chief Scientific Officer for Latona Life Sciences, he was President and CEO for Protein Therapeutics, Inc., a company dedicated to the development of new therapies for the treatment of immune-mediated diseases. Prior to Protein Therapeutics, he was President and CEO of Protein Technologies, Inc. He was President and CEO of Vega Biotechnologies, Inc. which was Arizona’s first public company. Dr. Barstow served on the Entrepreneurship Board of Advisors for Eller College of Management and the College of Engineering, Dean’s Advisory Council, at the University of Arizona. Dr. Barstow received his Bachelor of Science Degree in Chemistry and Physics from Edinboro University in Pennsylvania and his doctorate in Science from Syracuse University, New York.